Hit Identification of CK2 Inhibitors by Virtual Screening

Biopolymers and Cell - Ukraine
doi 10.7124/bc.00095b
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Institute of Molecular Biology and Genetics (NAS Ukraine)

Related search

Hit Identification for PKCζ Inhibitors: Structure-Based Optimization, Virtual Screening, and Biological Evaluation

English

Identification of Potential Inhibitors From Pyriproxyfen With Insecticidal Activity by Virtual Screening

Pharmaceuticals
Molecular MedicinePharmaceutical Science
2019English

Identification of Potential Mycobacterium Tuberculosis Beta-Ketoacyl Synthase Inhibitors by Virtual Screening

Revista Virtual de Quimica
MathematicsChemistry
2016English

Identification of Transthyretin Fibril Formation Inhibitors Using Structure-Based Virtual Screening

ChemMedChem
Organic ChemistryMolecular MedicinePharmacologyBiochemistryToxicologyDrug DiscoveryPharmaceutics
2017English

176 Structure-Based Virtual Screening Towards Identification of Potential FabH Inhibitors

Journal of Biomolecular Structure and Dynamics
MedicineMolecular BiologyStructural Biology
2013English

Identification of Novel Acetylcholinesterase Inhibitors Designed by Pharmacophore-Based Virtual Screening, Molecular Docking and Bioassay

Scientific Reports
Multidisciplinary
2018English

Fragment Screening Using Capillary Electrophoresis (CEfrag) for Hit Identification of Heat Shock Protein 90 ATPase Inhibitors

Journal of Biomolecular Screening
Molecular MedicinePharmacologyBiochemistryAnalytical ChemistryBiotechnologyDrug Discovery
2012English

Identification of Ellagic Acid as Potent Inhibitor of Protein Kinase CK2: A Successful Example of a Virtual Screening Application

English

Virtual Screening for Identification of Small Lead Compound Inhibitors of Nipah Virus Attachment Glycoprotein

Journal of Pharmacogenomics & Pharmacoproteomics
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy